Celiac Disease Treatment Market Size, Share, Opportunities, And Trends By Type (Vitamins And Dietary Supplements, Steroids And Immunosuppressive Drugs, Therapeutic Vaccines), And By Geography - Forecasts From 2025 To 2030

Celiac Disease Treatment Market Size:

The Celiac Disease Treatment Market is expected to grow from USD 501.820 million in 2025 to USD 961.137 million in 2030, at a CAGR of 13.88%.

Celiac Disease Treatment Market Introduction:

Celiac disease is a digestive disorder that makes it difficult for the body to absorb nutrients like fat, calcium, iron, and folate. Celiac disease is an autoimmune disease. Patients suffering from this disease have damaged lining of the small intestine owing to consumption of foods with gluten. Celiac diseases, being gene-based, are inherited by people, especially those having a family history of type 1 diabetes, autoimmune thyroid, down syndrome, rheumatoid arthritis, microscopic colitis, and Addison’s disease. The market for celiac disease treatment is projected to observe lucrative growth during the forecast period. The prime driver driving the growth in the market is robust growth in the development of various anti-inflammatory drugs and therapeutic vaccines which are expected to substitute for a gluten-free diet. Rising healthcare expenditure and investment have resulted in growing medical research which has fueled the market. furthermore, increasing awareness about the disease and steps taken by healthcare organization to spread awareness is expected to further bolster this growth. Geographically, Europe and North America's celiac disease treatment markets are the largest. High prevalence and a well-established healthcare landscape support the industry in these regions. Africa, on the other hand, is a market with great potential, given the fact that the highest prevalence of the disease is found in the Saharawi people of Africa.

Celiac Disease Treatment Market Trends:

The rising adoption of therapeutic products in developed and developing economies is a crucial factor that is expected to escalate market growth. Growing healthcare awareness and steps taken by various healthcare organizations have led to increasing health consciousness and also rising diabetes cases. Growing healthcare expenditure has encouraged favourable government policies across the world. Increased investment has raised the number of clinical trials for drugs against celiac disease. Increased consumption of foods such as fast food, ready-to-eat food, packed food, and others that are high in protein has increased gluten consumption which leads to celiac disease, increasing change in the trends in restaurants that offer ready-to-eat packaged foods, junk food, and beverage addiction, changing lifestyle, and increasing disposable income adds to the gluten intake which is a major factor drives the growth of celiac disease treatment market. Moreover, rising technological advancements and increasing modernization in the healthcare sector, and rising research and development activities will further create new opportunities for the celiac disease treatment market in the upcoming years.

However, limited availability of the treatment options in the market accompanied by no specific drug for the treatment of the disease, and the majority of patients suffering from celiac disease cases remain underdiagnosed/misdiagnosed acts as the major factors among others that will obstruct the market growth, and will further challenge the growth of celiac disease treatment market during the forecast period.

Celiac Disease Treatment Market Growth Factors:

• Rising prevalence of diabetes

One of the prime factors which are expected to drive the market for celiac disease is the growing prevalence of diabetes among all age groups. Diabetes is a blood-glucose chronic disease in which the body is unable to produce the required amount of blood glucose, or as scientifically known as insulin. Both excess and low insulin levels are harmful to the body. The rising prevalence of diabetes has raised serious concerns among government and healthcare organizations. A report published by the World Health Organization (WHO) shows that 1.5 million people faced death owing to diabetes. This chronic disease is also widely prevalent among children and adolescents, causing health problems. increasing diabetes cases has significantly raised the risk of Celia disease, creating market demand for celiac disease treatment.

Celiac Disease Treatment Market Competitive Insights:

The increasing need for celiac disease treatment caused by the rising occurrence of celiac disease due to changing lifestyles and the increasing prevalence of diabetes across the world has led to the entry of several new players like BioLineRx in the celiac disease treatment market. The entry of these new players in a market where traditional pharma behemoths like General Mills, Inc. and Glenmark Pharmaceuticals Inc. already exist, is expected to lead to further innovation in the trocars market. Moreover, to further increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and the development of novel solutions which primarily focus on providing comfort to the patient, which is expected to keep the market competitive and constantly evolving.

Celiac Disease Treatment Market Segmentation:

• By Type
  • Vitamins and Dietary Supplements
  • Steroids
  • Immunosuppressive Drugs
  • Therapeutic Vaccines
  • Enzyme Therapy
  • Gluten-Free Diet Products
  • Biologics
• By Route of Administration
  • Oral
  • Injectable
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. CELIAC DISEASE TREATMENT MARKET BY TYPE

5.1. Introduction

5.2. Vitamins and Dietary Supplements

5.3. Steroids

5.4. Immunosuppressive Drugs

5.5. Therapeutic Vaccines

5.6. Enzyme Therapy

5.7. Gluten-Free Diet Products

5.8. Biologics

6. CELIAC DISEASE TREATMENT MARKET BY ROUTE OF ADMINISTRATION

6.1. Introduction

6.2. Oral

6.3. Injectable

7. CELIAC DISEASE TREATMENT MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction

7.2. Hospital Pharmacies

7.3. Retail Pharmacies

7.4. Online Pharmacies

8. CELIAC DISEASE TREATMENT MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Type

8.2.2. By Route of Administration

8.2.3. By Distribution Channel

8.2.4. By Country

8.2.4.1. USA

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Type

8.3.2. By Route of Administration

8.3.3. By Distribution Channel

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Type

8.4.2. By Route of Administration

8.4.3. By Distribution Channel

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.2. Germany

8.4.4.3. France

8.4.4.4. Spain

8.4.4.5. Others

8.5. Middle East and Africa

8.5.1. By Type

8.5.2. By Route of Administration

8.5.3. By Distribution Channel

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.2. UAE

8.5.4.3. Others

8.6. Asia Pacific

8.6.1. By Type

8.6.2. By Route of Administration

8.6.3. By Distribution Channel

8.6.4. By Country

8.6.4.1. China

8.6.4.2. Japan

8.6.4.3. India

8.6.4.4. South Korea

8.6.4.5. Taiwan

8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Innovate Biopharmaceuticals Inc.

10.2. BioLineRx Ltd.

10.3. Takeda Pharmaceutical Company Ltd.

10.4. Glutenostics LLC

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Innovate Biopharmaceuticals Inc.

BioLineRx Ltd.

Takeda Pharmaceutical Company Ltd.

Glutenostics LLC